There may be discrepancies between the antiepileptic drug (AED) doses the physician believes the patient is taking and what is actually taken. This prospective study assesses the extent of the problem in one paediatric epilepsy clinic.
INTRODUCTION
There may be discrepancies between the antiepileptic drug (AED) doses the physician believes the patient is taking and what is actually taken. This may be due to poor compliance, i.e. the patient not taking the AED regime suggested by the physician: a major cause of treatment failure',". Studies show a high rate of poor compliance among out-patients3, and some of the reasons given by patients for 'poor compliance' have been reported".
However, errors can also be due to inaccuracies or omissions in note keeping. This kind of error can harm patient management when decisions are made about subsequent AED changes or when the wrong dose or regime is administered to a patient in hospital based on erroneous information recorded in the patient's medical charts. This situation is the converse of poor patient compliance.
This study was therefore designed to measure the accuracy of AED regime information recorded in the medical charts by one paediatric neurologist (WW) at one paediatric epilepsy clinic and to explore possible avoidable factors.
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METHODS
A questionnaire was administered to the parent by the clinical nurse specialist (CNS), on a clinic day (QD) with the physician blind. Background information and data on all AED dosages during the preceding 48 hours were recorded. The charts were later reviewed by the CNS and the AED doses documented as being taken up to the QD, and those documented as recommended to be taken from the previous clinic day (PCD) were recorded.
Fisher's exact test was used to assess statistical significance.
RESULTS
Of the 25 patients analysed, nine were female, and the ages ranged from 1 to 16 years (mean age 8 years). In this study however, there was no statistically significant relationship between nor having written information and having diJiculty understanding the regime (P = 0.28).
There were 14 discrepancies in total, affecting 12/25 patients (48%). Two were errors of current AED dosage information (for the QD) in the patient's medical charts (in 2/25 patients). Four of 25 patients (16%) were taking different AEDs to those intended on the PCD. Of the AEDs taken on both PCD and the QD, 8/36 AEDs (22%) in 8/25 patients (32%) were NOT being taken at the planned dose.
DISCUSSION
The patients studied were representative of the paediatric epilepsy clinic population. There were no major nor potentially dangerous errors in drug dosage, however, such major errors could still be occurring in this clinic population at a significant rate (95% confidence intervals O-12%).
Several possible contributing factors were assessed. Further efforts to encourage patients and their parents or guardians to understand and be positive about the treatment plan, take written instructions home and use them, and to bring all current medication to clinic appointments are now being implemented.
A brief information leaflet describing the clinic and its workings will highlight these factors and the physician and CNS will try harder and take time to gauge the family's understanding and will write treatment plans in the seizure diaries and send clinic letters to families routinely.
Two errors in the written dosage of AEDs being taken on the QD were identified, in one case the patient was taking less than planned and the planned dose was written as the actual dose being taken. This may have been due to the parents giving false information (covert poor compliance) or to the physician assuming he knew what the patient was taking.
This illustrates the arbitrary distinction between poor compliance and poor history taking and poor note keeping.
The stopping and starting of AEDs not included in the written plan on the previous clinic day was appropriate and had been medically sanctioned, either explicitly or implicitly in 8/25 patients. Four patients were taking a lower than planned dose and four patients a higher than planned dose. Nevertheless all were taking reasonable doses. In all, these discrepancies with the PCD treatment plan affected 11/25 patients (44%).
The interval between the PCD and the QD for these cases was l-3 months, no longer than for those adhering to the plan.
CONCLUSIONS
In this small survey of a paediatric epilepsy clinic 2/40 of the current AED regimes (5%) were inaccurately recorded in the medical charts. Furthermore 16% of patients had AED regimes substantially different from what had been planned and documented. A further 28% were taking the planned AEDs in doses different to those planned at the previous clinic visit.
These discrepancies were not harmful and were sanctioned, explicitly or implicitly, by the physician or CNS. However care should be taken when using AED regimes written in the patient's medical charts as even recent entries can be misleading: in this survey the previous clinic entry was misleading for 44% of patients for 30% of the AEDs being taken.
Focusing exclusively on the 'poor compliance' of a patient or his or her parents is only part of the picture. This study shows that apparent poor compliance may be an error in the physicians entry in the medical chart, or an artefact due to the lag time between AED adjustment and medical chart review. Future studies of patient compliance should be designed to control for these errors.
